{"name":"Bright Cell, Inc.","slug":"bright-cell-inc","ticker":"","exchange":"","domain":"","description":"Bright Cell, Inc. is a biotechnology company focused on developing innovative therapies in the early stages of clinical trials. The company currently has two drugs in phase 1 trials, BC-101 and YB-1113, targeting significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOX1M5WTEyMDNYZk5BamZGcXRGSXBtQUJLbjE5YmZUQlE5OWJldGM1SkM3emdVYUlhWEo5VE4zUXFEa1RCVld2R3NqamFIMGVTdmNaVnVmTXBiMGh4dDRQaDVHYlJzY1k4MEoxaHhGMllYYmppT29HbE01YjlQMTdCenJfeTBuS080eGFoQXpmZG5YMVlRcGRrdUh5QXhDOHBXT0sw?oc=5","date":"2026-02-24","type":"pipeline","source":"BioSpace","summary":"Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer - BioSpace","headline":"Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-19","type":"pipeline","source":"6abc Philadelphia","summary":"Johnson & Johnson investing $1B to build new cell therapy facility in Lower Gwynedd Township, Pennsylvania - 6abc Philadelphia","headline":"Johnson & Johnson investing $1B to build new cell therapy facility in Lower Gwynedd Township, Pennsylvania - 6abc Philad","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOc1JDS1FVQU1ZZEJQT3h6dmFUaDdELWdyX2FWX1VKWWVDYUFadHdPN29sZlpwNlZYM1FhX0JmUDczREZwMHBuZUprczAxQWRMWl83MDhXN2hXMGJxZEkzcUExSkhWRUlRZEVEbnBOWTNRNHQweWJmc3ZWNVgtYVpkdGloRDdxcnVRWE5aN09oY1ZYX0NQNjJWVmg4N3liY3U1dS1F?oc=5","date":"2025-12-30","type":"pipeline","source":"Investing News Network","summary":"Top 4 Canadian Biotech Stocks - Investing News Network","headline":"Top 4 Canadian Biotech Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOZDZON3pNd2RvNTNrbll6Z2pHQl9sTTB6eFpZbUp2dk8xN1N3OFN5enMwbWdlcVlNMm04U3VqTG9RaEQ3eXI0eDNRblZwaEpyUFprQ01KVXZkelhVZi1hdkJReDBFVEkwdVcyb0VDeks2c2lURkVXLWRjaGpZUWt2UGNjcUs5QU9TcVRjNl94bXlHbXY2Yjh5STMyMmNQbDhZLUFtNkR4blJTa0M0S1c0S1Z2dy1ndw?oc=5","date":"2025-12-29","type":"pipeline","source":"Seeking Alpha","summary":"Iovance Biotherapeutics: Bright Prospects For 2026 (NASDAQ:IOVA) - Seeking Alpha","headline":"Iovance Biotherapeutics: Bright Prospects For 2026 (NASDAQ:IOVA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE8xYk5Bd1dzY0lFN3R0V1Ziel9FWUF0ZC1jRzhSQzRMay1sT3h0Mk82V3UwU0RtQTlSMmh6V2czLWxyWEd5TUY3ZTl4VnZBdE5PcXEyS2p4b040ZmZGZUlmQTFEWVd5cGNmckx0Wk5wbU5PS0N5cEdpVWNiYUI?oc=5","date":"2025-12-19","type":"pipeline","source":"StocksToTrade","summary":"AST SpaceMobile’s Surprising Performance: A Bright Future Ahead? - StocksToTrade","headline":"AST SpaceMobile’s Surprising Performance: A Bright Future Ahead?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBNa0pTM28zMmtaczdsdEw0MS1GRzFBai13Mjd6SS1mZEtVcG8xMVU4OXV6cnh6MUJhdnNjNlZQdGJ4cUpfSUMwNWdUVUx1bVZKandRbkt1S00zYjlkVFNXal9aMGFQS2dHUXFJcG56MzhzU1hpcXc?oc=5","date":"2025-11-12","type":"pipeline","source":"Labiotech.eu","summary":"19 swiss biotech startups you’ll want to keep an eye on - Labiotech.eu","headline":"19 swiss biotech startups you’ll want to keep an eye on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPaVVxUUJHMF9kaTRQWmNEbUxZWWZpY252b0dia3RtRU94OHdQZERrZWw3OVNhWUpKNmpmdlZSQS1jaTBJbU9LR29rN0doNVdZU3ZXNFpjenpwdUlveFdWZnQ0NUFkbW9WeldxWjhWZ05LT1B1Z1ZURzVETUJiY1RsYkxNclVweklnQVlpaFphcmo?oc=5","date":"2024-12-20","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 cell and gene therapy leaders to watch in 2025 - drugdiscoverytrends.com","headline":"100 cell and gene therapy leaders to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"PR Newswire","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQNjBGN2xjRjJkMWlIclJ4TzBIcm1wdk1JSW5GazhzM243bzJ1SW9ic3RfS2FZYTBXa2lDRy1HNUVNZnU0WWtWZXpjYjdFV1pRY0NyTURabUtSaU9ldlNFeFBVdmtNblBFN3Nxek16dnlZTDk4RmFYSWVvLXE0U1JBeEd0ZXJWYzhjRWtsakxfU3Z3VjQ?oc=5","date":"2024-10-09","type":"pipeline","source":"The New York Times","summary":"Growing Cannabis and Opium Poppies May Be Key to U.S. Supply Chains (Published 2024) - The New York Times","headline":"Growing Cannabis and Opium Poppies May Be Key to U.S. Supply Chains (Published 2024)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNMTRaRWhpTDRpb0V1Qlpta25jMV9ZbnRxZ3FMenpPbC1Ga2NXMVpBY2lrTk53N05RN0x1ZjV2R3ZrNUhZRjRpS2x2ODA3aHoza2xmOXNXUzdjUHRRWURXeGhfWk1DMjlFREZEWURjVGlJZUVVWmdtc3EwZUFWdVpRcFM0NEstaDNVeWtwWWdLb0dReGlBTHpwWXNtYw?oc=5","date":"2024-08-05","type":"trial","source":"Pharma Voice","summary":"In a Duchenne market beset by problems, Capricor data marks a bright spot - Pharma Voice","headline":"In a Duchenne market beset by problems, Capricor data marks a bright spot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdlFKSGtiZHVjTnl6d3JDLU44dERUQ2pwdFFzdUEwUmF6ZTZINWFnSE1lTE84ZVN0aGVheXFOWUlKLUdZS2gxdUY3Vmd4ZlRWQzd3VjBkZFlieDRPbnBNS2RXcGlGaVI3YW9jUnhxN0MxU3hfWmRHbGlCYnVIMWNmNDlmdkdNc1JqM3NTcEk0Ml9DYjI4QVJKQ0ozc1JiRkRxN00ydDY1RlM5Vkx0OEQxazNjUDlxcmlxQjdGeHFNSnA?oc=5","date":"2023-01-10","type":"pipeline","source":"BioWorld News","summary":"J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM - BioWorld News","headline":"J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}